Innate Pharma's Abstracts Selected for ASCO 2025 Annual Meeting

Innate Pharma announced that four abstracts featuring its clinical-stage drugs will be presented at the American Society of Clinical Oncology (ASCO) 2...
Home/KnloSights/Clinical Trial Updates/Innate Pharma's Abstracts Selected for ASCO 2025 Annual Meeting